EL7.AI
Strategy BuilderCOT DataAdvanced NewsResearchNewEarnings CalendarEconomic Calendar
We use cookiesPrivacy Policy
EL7.AIEL7.AI

AI Financial Intelligence
Professional analysis of central bank decisions

© 2026 EL7.AI. All rights reserved.

Markets

  • News
  • Forex
  • Stocks
  • Crypto
  • Gold
  • Commodities
  • Indices
  • ETFs

Analysis

  • Fed
  • ECB
  • BLS
  • COT
  • Economic Calendar

Learn

  • Service Guide
  • Oil

Company

  • About
  • Contact
  • Data Methodology
  • AI Disclosure
  • Pricing
  • Enterprise
  • Terms
  • Privacy
  • Security
  • WhatsApp
Status data is currently unavailable

The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

Home
Stocks
Nutrien Ltd.
EL7 Factor Analysis
How we score this
Overall87
Excellent — top fifth of the marketSuper StockF 7/8Better than 87% of Market stocks, per EL7's model
FactorScoreDistributionValueAvgRank
▸
Valuation
78
15.9x▲17.8xTop tier
▸
Growth
29
8.6%▲7.1%Bottom tier
▸
Quality
52
8.8%▲4.5%Around median
▸
Safety
65
1.9x▲2.6xAround median
▸
Capital Return
78
2.78%▲2.12%Top tier
▸
Momentum
74
14.2%▲2.9%Top tier
▸
Sentiment
85
11▲3Top tier
NTR

NTR Nutrien Ltd.

Nutrien Ltd. · NYSE
Market Closed
78.45
▼ ⁦-0.36%⁩ (-0.28)
Market Cap$37.7B
Beta1.06
52w Low52w High
53.0385.36
Last Week
⁦+0.98%⁩
Last Month
⁦+18.31%⁩
Last 3 Months
⁦+18.24%⁩
Last Year
⁦+36.86%⁩
Fair Value
Current price$78
Analyst target · 5 analysts
$79
⁦+1%⁩
See it fairly priced
Range ⁦$63–$100⁩
vs
DCF (estimate)
$35
⁦-55%⁩
Sees it clearly overvalued
⁦9.1⁩% discount · ⁦0⁩% growth
Bottom lineThe two methods disagree — estimate range ⁦$35–$79⁩.

Estimates — analyst targets and a simplified DCF, not investment advice.

Compare in the screener
Premium content

Get Your Premium Account Now

  • Stock Deep Analysis
  • The Advanced News Platform
Recommended
Annual plan
$17/mo
Monthly plan
$29/mo

Analyst Consensus

This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.

Price Target· 5 analysts setting price target
$79.13
⁦+0.9%⁩
Current Price $78.45·Median $79.00
Low
$63.00
High
$100.00
Current price
$78.45
Average target
$79.13
Street summary

Target Stable with a Slightly Cautious Bias

The consensus price target remained stable at 79.13 from five analysts over the last 7 days, compared with a slight decrease of 0.30, or 0.38%, over the last 30 days from 79.43. The current range is between 63 and 100, while the current price stands at 78.45, near the consensus and the median of 79, reflecting clear dispersion among estimates without any recent change in the number of analysts.

As of 2026-09-11
Revisions momentum · 30d
⁦-0.4%⁩
Average rating
★ 3.83
Buy
Analyst coverage
24
Buy conviction
63%
Mixed
Rating activity · 30d
0↑ · 1↓
Target dispersion
47%
Wide
Analyst ratings over time24 analysts rating
7
8
7
2
Strong BuyBuyHoldSellStrong Sell
Rating trend — last 12 months3.63 → 3.83
Recent analyst moves
  • = Reiterate2026-09-10
    KeyBanc
    Sector Weight
  • ⬇ Downgrade2026-08-25
    National Bank
    Sector Perform
  • = Reiterate2026-08-10
    Barclays
    Overweight
Premium content
Key Financials

Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.

StockSector medianSector averagetypical sector range
MetricValuePosition within sectorVerdict
  • P/E (TTM)
    15.88x
    4.94x39.51x
    Cheap
  • Forward P/E
    13.42x
    3.70x29.59x
    Cheap
  • EV / EBITDA
    7.85x
    2.62x20.92x
    Cheap
  • FCF Yield
    5.7%
    -21.3%8.9%
    Strong
  • Revenue Growth YoY
    8.6%
    -21.2%90.4%
    Below average
  • EPS Growth YoY
    76.5%
    -249.5%198.4%
    Strong
  • Gross Margin
    31.0%
    7.6%58.9%
    Near median
  • ROIC
    8.8%
    -52.6%20.2%
    Strong
  • Net Debt / EBITDA
    1.87x
    0.22x3.72x
    Near median
  • Dividend Yield
    2.8%
    0.2%5.5%
    Moderate
  • Payout Ratio
    44.1%
    4.7%147.8%
    Moderate
  • Altman Z-Score
    —
    —
Financial Analysis
|

Stock Analysis

AI-generated
Based on 2026-08-06 data

Company Overview

Nutrien operates across the agricultural value chain, from fertilizer production to the distribution of inputs and services to farmers. The company generates earnings from six low-cost potash mines, nitrogen assets in North America, phosphate operations, and a retail network that sells crop nutrients, crop protection products, seeds, and proprietary products and provides agricultural services; in Australia, revenue also includes commissions from helping farmers sell sheep and cattle. The potash and nitrogen businesses benefit from prices and volumes, while proprietary products and retail margins provide the company with a more diversified source of earnings.

In Q2 of fiscal 2026, Nutrien reported net income of $1.22 billion and adjusted earnings before interest, taxes, depreciation, and amortization of approximately $2.4 billion. Potash adjusted earnings before interest, taxes, depreciation, and amortization were $658 million, and nitrogen generated $635 million, while phosphate earnings declined due to higher sulfur costs. For the first half of fiscal 2026, adjusted earnings before interest, taxes, depreciation, and amortization reached $3.5 billion, up 6%, and cash generated from operating activities increased 12%.

Retail generated adjusted earnings before interest, taxes, depreciation, and amortization of $1.24 billion in the first half of fiscal 2026, up 4%, despite weaker commodity fertilizer volumes. Total gross margin from proprietary crop nutrients increased 10% in the first half, while total gross margin from proprietary products increased 16% in Q2, supported by the launch of 26 new products and an increase in sales of certain agricultural nutrition products to nearly ten times their level a year earlier. For the annual comparison, fiscal 2025 revenue increased to $26.9 billion from $26.0 billion in fiscal 2024, and net income rose to $2.3 billion from $700 million, with earnings per share increasing to $4.66 from $1.36.

What's Driving the Stock

  • Nutrien raised the lower end of its fiscal 2026 potash sales volume guidance to a range of 14.2–14.8 million tonnes following record first-half volumes and improved order book visibility; Canpotex sales for Q3 of fiscal 2026 were fully committed, while the company maintained its global shipment estimate at 74–77 million tonnes.
  • Automation supports potash expansion and cost efficiency; 53% of ore tonnes were mined autonomously in the first half of fiscal 2026, with a target of controllable cash cost below $60 per tonne for the full year. The company estimates that increasing capacity from approximately 15 million tonnes to 18 million tonnes would require $200–300 per tonne of additional capacity and approximately one year to make additional volumes available.
  • Nutrien launched 26 proprietary products during fiscal 2026, and total gross margin from proprietary products increased 16% in Q2, while management is targeting high-single-digit growth in total gross margin from these products during the year. Sales of certain agricultural nutrition products also increased to nearly ten times the prior-year level, supporting retail growth despite lower commodity fertilizer volumes.
  • The company maintained its fiscal 2026 retail adjusted earnings before interest, taxes, depreciation, and amortization guidance at $1.75–1.95 billion, expecting higher crop nutrient margin per tonne to offset part of the volume decline. The midpoint of the range also reflects the performance of crop protection products, an improving outlook for winter cropping in Australia, and strong livestock markets.
  • Nutrien reduced its fiscal 2026 capital expenditure guidance by $50 million to $1.95–2.05 billion and increased share repurchases by 26% in the first half compared with the prior year. It raised the pace of repurchases in Q3 of fiscal 2026 to approximately $75 million per month, compared with approximately $50 million per month at the beginning of the year.
  • Since June 2026, the company has completed agreements to sell non-core assets for total proceeds of approximately $90 million, bringing divestiture proceeds since Q4 of fiscal 2024 to approximately $1 billion. Nutrien is reviewing strategic alternatives for its phosphate business, nitrogen operations in Trinidad, and each component of its Brazilian retail business, targeting a determination of the optimal path during fiscal 2026.

Buying & Selling Case

▲ Buying Case4 pts

  • +Nutrien achieved cash flow and operating momentum in the first half of fiscal 2026; adjusted earnings before interest, taxes, depreciation, and amortization increased 6% to $3.5 billion, and cash generated from operating activities rose 12%, enabling the company to reduce capital expenditure guidance and accelerate share repurchases.
  • +Potash represents a strong driver due to record sales volumes, the increase in the lower end of guidance to 14.2 million tonnes, Canpotex being fully committed for Q3 of fiscal 2026 volumes, and a network of six mines targeting controllable cash cost below $60 per tonne.
  • +Growth in proprietary products provides an earnings layer that is less dependent on commodity fertilizer volumes; total gross margin from these products increased 16% in Q2 of fiscal 2026, and the company launched 26 products, while total gross margin from proprietary crop nutrients increased 10% in the first half.
  • +Annual performance improved significantly in fiscal 2025, as net income increased to $2.3 billion from $700 million in fiscal 2024, and earnings per share rose to $4.66 from $1.36, although revenue of $26.9 billion remained below the fiscal 2023 level of $29.1 billion.

▼ Selling Case6 pts

Valuation

The average analyst price target is $79.13, below the 52-week range high of $85.36, while the target range extends from $63 to $100 compared with an annual share-price range of $53.03 to $85.36; this breadth reflects substantial disagreement about the sustainability of the fertilizer earnings cycle. The consensus rating is Buy, but the absence of an available price-to-earnings ratio and the fluctuation in net income from $7.7 billion in fiscal 2022 to $700 million in fiscal 2024 and then $2.3 billion in fiscal 2025 make NTR's valuation highly dependent on fertilizer prices, volumes, and margins.

BuyAnalyst target: $79.13(+0.9%)

Figures in the text are as of 2026-08-28; the live price is shown at the top of the page.

FAQ

What drove NTR's results in Q2 of fiscal 2026?

Nutrien reported net income of $1.22 billion and adjusted earnings before interest, taxes, depreciation, and amortization of approximately $2.4 billion in Q2 of fiscal 2026. Potash generated $658 million of adjusted earnings before interest, taxes, depreciation, and amortization, supported by higher benchmark prices, operational execution, and the supply chain. Nitrogen generated $635 million, while higher sulfur costs pressured phosphate. For the first half, adjusted earnings before interest, taxes, depreciation, and amortization increased 6% to $3.5 billion, and operating cash flow rose 12%.

How important is the potash business to the Nutrien investment thesis?

Nutrien achieved record potash sales volumes in the first half of fiscal 2026, then raised the lower end of its full-year guidance to 14.2 million tonnes within a range of 14.2–14.8 million tonnes. Canpotex was fully committed for Q3 of fiscal 2026 volumes, and the company maintained its global shipment forecast at 74–77 million tonnes. The six-mine network is targeting controllable cash cost below $60 per tonne, and 53% of ore tonnes were mined using automation in the first half. Management sees the potential to increase capacity from approximately 15 million tonnes to 18 million tonnes at a cost of $200–300 per additional tonne and with approximately one year required to make the volumes available.

Earnings callEDGAR filings30-day newsInsider activity

Automated analysis for informational purposes only — not investment advice.

  • −The retail business faces tangible weakness in fertilizer volumes; in Q2 of fiscal 2026, phosphate volumes declined approximately 10% and nitrogen volumes approximately 7%, which management attributed to weak phosphate demand, reduced corn acreage, a delayed planting season in Western Canada, and the deferral of some purchases.
  • −Phosphate profitability came under direct pressure from higher sulfur prices, leading to a decline in the segment's adjusted earnings before interest, taxes, depreciation, and amortization in Q2 of fiscal 2026. Management described the pressure on global producer margins as unsustainable and acknowledged that contribution margins from its operations could change with fluctuations in the sulfur market.
  • −Nitrogen sales volumes declined in Q2 of fiscal 2026 due to production outages in Trinidad and New Madrid, planned maintenance at Carseland, and the deferral of some customer purchases. The Q3 plan also includes maintenance at the Lima and Redwater facilities, while maintaining full-year volume guidance of 9.2–9.7 million tonnes depends partly on higher ammonia operating rates in Q4.
  • −Retail selling, general, and administrative expenses increased approximately 6% in the first half of fiscal 2026, with higher fuel and fleet costs resulting from rising global energy prices as the largest factor. This inflation limits the segment's ability to capture the full benefit of proprietary product growth and improved margins per tonne.
  • −Supply chains and agricultural markets remain exposed to multiple external factors; management cited disruptions to nitrogen trade flows, production outages, and higher energy prices, and linked reaching the upper end of the 77 million tonne global potash shipment estimate to available supply-chain capacity. In Australia, the Chinese government imposed restrictions on certain Australian imports, although the company had not observed an impact on livestock prices as of the August 6, 2026 call.
  • −The annual financial statements reveal the sensitivity of earnings to the fertilizer cycle; revenue declined from $37.9 billion and net income from $7.7 billion in fiscal 2022 to $26.9 billion and $2.3 billion, respectively, in fiscal 2025. The wide range of analyst targets between $63 and $100 also reflects significant differences in estimates of the earnings trajectory, and the data does not include a valid price-to-earnings ratio that would provide an additional valuation anchor.
Can Nutrien's proprietary products offset weakness in commodity fertilizers?

Total gross margin from proprietary products increased 16% in Q2 of fiscal 2026, and total gross margin from proprietary crop nutrients increased 10% in the first half. The company launched 26 products during the year, and sales of certain agricultural nutrition products reached nearly ten times their level a year earlier. Management is targeting high-single-digit growth in total gross margin from proprietary products during fiscal 2026. However, this growth only partially offset volume weakness, as retail phosphate volumes declined approximately 10% and nitrogen volumes approximately 7% in Q2.

What are Nutrien's key guidance figures for fiscal 2026?

The company raised the lower end of its potash sales guidance to 14.2 million tonnes, bringing the range to 14.2–14.8 million tonnes, and maintained nitrogen sales guidance at 9.2–9.7 million tonnes. It also maintained retail adjusted earnings before interest, taxes, depreciation, and amortization guidance at $1.75–1.95 billion. The capital expenditure range was reduced by $50 million to $1.95–2.05 billion. In Q3 of fiscal 2026, the company increased the pace of share repurchases to approximately $75 million per month.

What are the main operational risks facing NTR?

Retail is experiencing lower phosphate and nitrogen volumes, while management expects phosphate demand to remain below historical levels during the second half of fiscal 2026. Higher sulfur prices are pressuring phosphate margins, while nitrogen volumes were affected by production outages in Trinidad and New Madrid and maintenance at Carseland. Retail selling, general, and administrative expenses increased approximately 6% in the first half due to fuel and fleet costs. Reaching the upper end of the 77 million tonne global potash shipment estimate also requires sufficient capacity across the global supply chain.

What does Nutrien's capital return and portfolio adjustment policy look like?

Nutrien increased share repurchases by 26% in the first half of fiscal 2026 compared with the prior year, then raised the pace to approximately $75 million per month in Q3. Since Q4 of fiscal 2024, asset divestitures have generated approximately $1 billion in total proceeds, including agreements totaling approximately $90 million completed since June 2026. The company is reviewing strategic alternatives for its phosphate business, nitrogen operations in Trinidad, and components of its Brazilian retail business. Management stated that it is targeting a determination of the optimal path for these businesses during fiscal 2026.